Meet the expert sessions at the 24th Annual EAU Congress

March 12, 2009

Arnhem, 12 March 2009 - At the forthcoming 24th Annual EAU Congress in Stockholm (SE), which will start on Tuesday 17 March, the EAU will be organizing three Meet the Expert sessions. These are press meetings on various subjects with expert urologists. They will be held in the Press Centre of the congress venue. In these sessions, members of the press have the opportunity to ask the experts their questions practically one-on-one.

The first session's subject is Male incontinence and will be organised on Wednesday 18 March from 15:00 to 15:30 hours. It is chaired by Prof Paul Abrams who will discuss the latest developments in this area. He is considered one of the world's leading experts in the field of lower urinary tract dysfunction. He is currently Professor of Urology, University of Bristol (UK). Paul Abrams has served as General Secretary of the International Continence Society (ICS). He was Chairman of the International WHO Consultations on Incontinence.

Prof Kurt Naber will be chairing the second session about the International Consultation on Urological Diseases (ICUD) on Thursday 19 March 2009 from 14:30 to 15:00 hours. The ICUD is organising global consultations on urological diseases, under the cosponsorship of the World Health Organization (WHO), the International Society of Urology (SIU), and the International Union Against Cancer (UICC).

The aim of the ICUD is to improve, with concerted efforts, the management and reduce the prevalence of urinary tract infections as well as the development of bacterial resistance. Another objective is to arrive at a consensus, which will be laid down in a textbook on urogenital infections with contributions of an international faculty consisting of about 100 recognised experts.

Kurt Naber is Professor of Urology at the Technical University of München (GE), School of Medicine. He is an expert in urological infections, especially the treatment of urinary tract infections and prostatitis. He will be chairing this year's ICUD.

Professor of Urology at Düsseldorf University (GE), Prof Peter Albers, will be chairing the third and last session on Testicular and penile cancer, Thursday 19 March 2009 from 15:30 to 16:00 hours. He is an active member of German Association of Urology (DGU), European Association of Urology (EAU), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC), among others.

A report of the sessions will be published on the EAU websites, www.uroweb.org and www.eaustockholm2009.org.
-end-
For more information please contact Ms Lindy Brouwer, l.brouwer@uroweb.org.

European Association of Urology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.